SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

     

FORM 8-K
   
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
     
Date of report: November 8, 1999
Date of earliest event reported: November 4, 1999
 
PFIZER INC.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction of incorporation)
1-3619
(Commission File Number)
13-5315170
(I.R.S. Employer Identification No.)
 
235 East 42nd Street
New York, New York
(Address of principal executive offices)
 10017
(Zip Code)
 
Registrant's telephone number, including area code:
(212) 573-2323
 

 

 

Item 5. Other Events

Attached and incorporated herein by reference as Exhibit 99.1 and Exhibit 99.2, respectively, are copies of (1) a press release of Pfizer Inc. announcing it had made an offer to acquire all of the outstanding shares of Warner-Lambert Company and (2) a statement of clarification relating to Pfizer Inc.'s offer to acquire all of the outstanding shares of Warner-Lambert Company.

 

Item 7(c). Exhibits
99.1
 Press release dated November 4, 1999 announcing an offer by Pfizer Inc. to acquire all of the outstanding shares of Warner-Lambert Company.
   
99.2
 Statement of clarification dated November 4, 1999 relating to Pfizer Inc.'s offer to acquire all of the outstanding shares of Warner-Lambert Company.

 

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

 

 

PFIZER INC.
Dated: November 8, 1999

 

 

By: /s/ MARGARET M. FORAN
Name: Margaret M. Foran
Title: Vice President- Corporate Governance

 

 

 

Index to Exhibits
99.1
 Press release dated November 4, 1999 announcing an offer by Pfizer Inc. to acquire all of the outstanding shares of Warner-Lambert Company.
   
99.2
 Statement of clarification dated November 4, 1999 relating to Pfizer Inc.'s offer to acquire all of the outstanding shares of Warner-Lambert Company.